Denali Therapeutics Inc. (DNLI) PT Raised to $42 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Andrew Fein raised the price target on Denali Therapeutics Inc. (NASDAQ: DNLI) to $42.00 (from $32.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
